Altimmune, Inc. Intellectual Property Contracts & Agreements

9 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No. 6 to the Second Restated License Agreement, effective as of January 22, 2021, between Janssen Vaccines & Prevention B.V. (formerly Crucell Holland B.V.) and...
License Agreements
Altimmune, Inc.
Biotechnology
2021
Amendment No. 5 to Second Restated License Agreement, effective as of October 22, 2020, between Janssen Vaccines & Prevention B.V. (formerly Crucell Holland B.V.) and Altimmune,...
License Agreements
Altimmune, Inc.
Biotechnology
2021
Amendment No. 4 to the Second Restated License Agreement, by and among Altimmune, Inc. and Janssen Vaccines & Prevention B.V., dated as of July 28, 2020
License Agreements
Altimmune, Inc.
Biotechnology
2020
Amendment No. 3 to the Second Restated License Agreement, by and among Altimmune, Inc. and Janssen Vaccines & Prevention B.V., dated as of April 2, 2020
License Agreements
Altimmune, Inc.
Biotechnology
2020
Amendment No. 2 to the Second Restated License Agreement, by and among Altimmune, Inc. and Janssen Vaccines & Prevention B.V., dated as of September 20, 2016
License Agreements
Altimmune, Inc.
Biotechnology
2020
Amended and Restated License Agreement, dated July 12, 2019, by and between Mederis Diabetes, LLC and Spitfire Pharma, Inc
License Agreements
Altimmune, Inc.
Biotechnology
CA
2019
AMENDMENT NO. 1 TO SECONDRESTATED LICENSE AGREEMENT
License Agreements
Altimmune, Inc.
Biotechnology
2017
First Amendment to Amended and Restated Exclusive License Agreement
License Agreements
Altimmune, Inc.
Biotechnology
2017
AMENDED AND RESTATED EXCLUSIVE LICENSE AGREEMENT
License Agreements
Altimmune, Inc.
Biotechnology
AL
2017